Belpointe Asset Management LLC Johnson & Johnson Transaction History

Belpointe Asset Management LLC

$1.28 Billion
Q2 2024

A detailed history of Belpointe Asset Management LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Belpointe Asset Management LLC holds 23,404 shares of JNJ stock, worth $3.79 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

23,404

Previous 19,895 17.64%

Holding current value

$3.79 Million

Previous $3.15 Million 8.67%

% of portfolio

0.27%

Previous 0.25%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$144.38 - $157.78 $506,629 - $553,650	3,509 Added 17.64%	23,404 $3.42 Million
Q1 2024 May 08, 2024	SELL	$155.22 - $162.74 $372,993 - $391,064	-2,403 Reduced 10.78%	19,895 $3.15 Million
Q4 2023 Feb 13, 2024	SELL	$145.6 - $158.88 $1.33 Million - $1.45 Million	-9,137 Reduced 29.07%	22,298 $3.49 Million
Q3 2023 Nov 15, 2023	SELL	$155.75 - $174.48 $1.7 Million - $1.9 Million	-10,918 Reduced 25.78%	31,435 $4.9 Million
Q2 2023 Aug 14, 2023	SELL	$154.35 - $166.11 $6.65 Million - $7.16 Million	-43,108 Reduced 50.44%	42,353 $7.01 Million
Q1 2023 May 15, 2023	BUY	$151.05 - $180.26 $946,932 - $1.13 Million	6,269 Added 7.92%	85,461 $13.2 Million
Q4 2022 Feb 08, 2023	BUY	$160.2 - $179.79 $2.56 Million - $2.87 Million	15,981 Added 25.28%	79,192 $14 Million
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $2.65 Million - $2.95 Million	16,408 Added 35.06%	63,211 $10.3 Million
Q2 2022 Aug 02, 2022	BUY	$168.19 - $186.01 $2.47 Million - $2.74 Million	14,712 Added 45.84%	46,803 $8.31 Million
Q1 2022 Apr 28, 2022	BUY	$158.14 - $179.59 $631,769 - $717,462	3,995 Added 14.22%	32,091 $5.69 Million
Q4 2021 Feb 15, 2022	SELL	$155.93 - $173.01 $26,352 - $29,238	-169 Reduced 0.6%	28,096 $4.81 Million
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $374,195 - $415,831	2,317 Added 8.93%	28,265 $4.57 Million
Q2 2021 Aug 09, 2021	SELL	$159.48 - $171.07 $53,744 - $57,650	-337 Reduced 1.28%	25,948 $4.28 Million
Q1 2021 May 14, 2021	BUY	$153.07 - $170.48 $636,311 - $708,685	4,157 Added 18.79%	26,285 $4.32 Million
Q4 2020 Feb 16, 2021	SELL	$137.11 - $157.38 $340,307 - $390,617	-2,482 Reduced 10.09%	22,128 $3.48 Million
Q3 2020 Nov 13, 2020	SELL	$140.38 - $153.83 $1.13 Million - $1.24 Million	-8,081 Reduced 32.08%	17,107 $2.24 Million
Q3 2020 Nov 13, 2020	BUY	$140.38 - $153.83 $1.05 Million - $1.15 Million	7,503 Added 43.86%	24,610 $3.67 Million
Q2 2020 Jul 20, 2020	BUY	$128.81 - $155.51 $1.04 Million - $1.26 Million	8,081 Added 47.24%	25,188 $3.54 Million
Q1 2020 Jul 20, 2020	SELL	$111.14 - $153.99 $303,745 - $420,854	-2,733 Reduced 13.78%	17,107 $2.24 Million
Q4 2019 Feb 18, 2020	BUY	$127.5 - $146.44 $577,957 - $663,812	4,533 Added 29.61%	19,840 $2.89 Million
Q3 2019 Jan 16, 2020	BUY	$126.95 - $142.14 $31,991 - $35,819	252 Added 1.67%	15,307 $1.98 Million
Q2 2019 Nov 22, 2019	SELL	$131.15 - $144.24 $692,472 - $761,587	-5,280 Reduced 25.97%	15,055 $0
Q1 2019 Jun 11, 2019	BUY	$125.72 - $139.79 $624,199 - $694,057	4,965 Added 32.3%	20,335 $2.84 Million
Q4 2018 Mar 06, 2019	BUY	$122.84 - $147.84 $21,374 - $25,724	174 Added 1.15%	15,370 $1.98 Million
Q3 2018 Nov 23, 2018	BUY	$121.58 - $142.88 $753,309 - $885,284	6,196 Added 68.84%	15,196 $2.1 Million
Q2 2018 Aug 06, 2018	BUY	$119.4 - $131.76 $173,010 - $190,920	1,449 Added 19.19%	9,000 $1.09 Million
Q1 2018 Aug 06, 2018	SELL	$125.1 - $148.14 $376,425 - $445,753	-3,009 Reduced 28.49%	7,551 $968,000
Q4 2017 Feb 15, 2018	BUY	$131.22 - $143.62 $24,669 - $27,000	188 Added 1.81%	10,560 $1.48 Million
Q3 2017 Nov 16, 2017	BUY	$129.47 - $135.38 $1.34 Million - $1.4 Million	10,372	10,372 $1.35 Million

Others Institutions Holding JNJ

# of Institutions

4,162

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $424B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belpointe Asset Management LLC with notifications on news.

Account

Belpointe Asset Management LLC Johnson & Johnson Transaction History